ioTracker Cells, the new range within bit.bio's ioCells portfolio, deliver added visualisation capabilities that enhance the portfolio of deterministically-programmed human iPSC-derived cells powered ...

A research team has identified the core gene expression networks regulated by key proteins that fundamentally drive phenomena such as cancer development, metastasis, tissue differentiation from stem ...

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...

The research teams at LV Prasad Eye Institute under the Centre for Ocular Regeneration (CORE) at the Brien Holden Research Centre, organized the second edition of the ‘Future is Here’.

Colossal Biosciences is working to bring back species like the woolly mammoth using CRISPR-Cas9 technology. The project aims to restore lost biodivers ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Beam Therapeutics shows promise in gene therapy for sickle cell disease, but it also has high risks and market expectations.

This is a useful study that seeks to address the role of the TET family of DNA demethylation enzymes in pancreatic beta cell senescence in the context of type 2 diabetes (T2DM). Although the concepts ...

STEM Potential supports you through years 10 and 12 with insightful lectures, subject-specific workshops and a non-residential summer school. STEM Potential is a multi-year programme of activities and ...

Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This ...